MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Law, P. Y.
Right arrow Articles by Loh, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Law, P. Y.
Right arrow Articles by Loh, H. H.

Loss of opiate receptor activity in neuroblastoma X glioma NG108-15 hybrid cells after chronic opiate treatment. A multiple-step process

PY Law, DS Hom and HH Loh

Treatment of NG108-15 cells with 1 nM or 10 nM etorphine for 24 hr produced an identical magnitude of compensatory increase in prostaglandin E1-stimulated adenylate cyclase activity. Activity of etorphine was retained, albeit reduced, in NG108-15 cells treated with 1 nM etorphine but not in cells treated with 10 nM etorphine. Exposure to 100 microM morphine for 72 hr produced a complete loss of morphine and levorphanol but not Leu5-enkephalin activity in NG108-15 hybrid cells. Apparently, the loss of opiate activity involves a multiple-step process. Short-term incubation with 10 nM etorphine (less than 3 hr) produced loss of opiate activity with minimal alteration in [3H]diprenorphine specific binding. Long-term exposure to 10 nM etorphine (greater than or equal to 24 hr) produced down-regulation of the receptor. A mechanism similar to that of beta-adrenergic receptor desensitization may be involved in opiate receptor desensitization in NG108-15 cells.

Volume 22, Issue 1, pp. 1-4, 07/01/1982
Copyright © 1982 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
H. Zhao, H. H. Loh, and P. Y. Law
Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor Internalization
Mol. Pharmacol., April 1, 2006; 69(4): 1421 - 1432.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Wang, H. H. Loh, and P.-Y. Law
The Intracellular Trafficking of Opioid Receptors Directed by Carboxyl Tail and a Di-leucine Motif in Neuro2A Cells
J. Biol. Chem., September 19, 2003; 278(38): 36848 - 36858.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. P. McLaughlin, M. Xu, K. Mackie, and C. Chavkin
Phosphorylation of a Carboxyl-terminal Serine within the {kappa}-Opioid Receptor Produces Desensitization and Internalization
J. Biol. Chem., September 5, 2003; 278(36): 34631 - 34640.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. H. Tso and Y. H. Wong
Gz Can Mediate the Acute Actions of {micro}- and kappa -Opioids but Is Not Involved in Opioid-Induced Adenylyl Cyclase Supersensitization
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 168 - 176.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
P.-Y. Law and H. H. Loh
Regulation of Opioid Receptor Activities
J. Pharmacol. Exp. Ther., May 1, 1999; 289(2): 607 - 624.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
Y. Shoji, J. Delfs, and J. T. Williams
Presynaptic Inhibition of GABAB-Mediated Synaptic Potentials in the Ventral Tegmental Area during Morphine Withdrawal
J. Neurosci., March 15, 1999; 19(6): 2347 - 2355.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. L. Ingram, C. W. Vaughan, E. E. Bagley, M. Connor, and M. J. Christie
Enhanced Opioid Efficacy in Opioid Dependence Is Caused by an Altered Signal Transduction Pathway
J. Neurosci., December 15, 1998; 18(24): 10269 - 10276.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. E. Keith, B. Anton, S. R. Murray, P. A. Zaki, P. C. Chu, D. V. Lissin, G. Monteillet-Agius, P. L. Stewart, C. J. Evans, and M. v. Zastrow
µ-Opioid Receptor Internalization: Opiate Drugs Have Differential Effects on a Conserved Endocytic Mechanism In Vitro and in the Mammalian Brain
Mol. Pharmacol., March 1, 1998; 53(3): 377 - 384.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. M. Harrison, A. J. Kastin, and J. E. Zadina
Tyr-W-MIF-1 Attenuates Down-Regulation of Opiate Receptors in SH-SY5Y Human Neuroblastoma Cells
J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 611 - 617.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Cvejic and L. A. Devi
Dimerization of the delta  Opioid Receptor:. IMPLICATION FOR A ROLE IN RECEPTOR INTERNALIZATION
J. Biol. Chem., October 24, 1997; 272(43): 26959 - 26964.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Chakrabarti, W. Yang, P.-Y. Law, and H. H. Loh
The µ-Opioid Receptor Down-Regulates Differently from the delta -Opioid Receptor: Requirement of a High Affinity Receptor/G Protein Complex Formation
Mol. Pharmacol., July 1, 1997; 52(1): 105 - 113.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
A. Bonci and J. T. Williams
Increased Probability of GABA Release during Withdrawal from Morphine
J. Neurosci., January 15, 1997; 17(2): 796 - 803.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Chieng and M. J. Christie
Local Opioid Withdrawal in Rat Single Periaqueductal Gray Neurons In Vitro
J. Neurosci., November 15, 1996; 16(22): 7128 - 7136.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Cvejic, N. Trapaidze, C. Cyr, and L. A. Devi
Thr[IMAGE], Located within the COOH-terminal Tail of the [IMAGE] Opiate Receptor, Is Involved in Receptor Down-regulation
J. Biol. Chem., February 23, 1996; 271(8): 4073 - 4076.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. L. Whistler, P. Tsao, and M. von Zastrow
A Phosphorylation-regulated Brake Mechanism Controls the Initial Endocytosis of Opioid Receptors but Is Not Required for Post-endocytic Sorting to Lysosomes
J. Biol. Chem., August 31, 2001; 276(36): 34331 - 34338.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1982 by the American Society for Pharmacology and Experimental Therapeutics